Israel vs Marshall Islands: Previously treated cases tested for RR-/MDR-TB
Israel
100.0%
in 2024
Marshall Islands
100.0%
in 2024
Israel rank
1st
Marshall Islands rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Israel
- Marshall Islands
How they compare
Israel currently reports 100.0% against 100.0% in Marshall Islands, a difference of 0.0%.
The two have swapped places 3 times across 18 shared years of data; in 2005 it was Israel ahead.
Israel ranks 1st and Marshall Islands ranks 1st of 180 countries.
Israel has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Israel | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 67.5% | 54.5% | 13.0% | Israel |
| 2010s | 59.6% | 45.4% | 14.1% | Israel |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Israel or Marshall Islands?
- Israel, at 100.0% against 100.0% in Marshall Islands as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Israel and Marshall Islands?
- 0.0%, with Israel ahead.
- How many years of comparable data are there for Israel and Marshall Islands?
- 18 years are reported by both, from 2005 to 2024.
- How do Israel and Marshall Islands rank globally for previously treated cases tested for rr-/mdr-tb?
- Israel ranks 1st and Marshall Islands ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.